
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
TargImmune Therapeutics AG is a private Swiss-based biotechnology company developing a novel targeted cancer treatment modality. TargImmune has a unique dsRNA non-viral vector delivery platform which, by mimicking a virus, harnesses the bodys powerful antiviral defenses to address cancer tumors including distant metastases. The targeted nanoparticles drive a combination of apoptosis (cell death) and modulation of the innate and adaptive immune cells to target both primary and metastatic heterogeneous tumour cells. TargImmunes therapeutics are the first in a new class known as Targeted Apoptotic Immune Modulators (TAIMs). TargImmunes unique viral mimicry approach is fundamentally different to any of the other...
Oncology,nanomedicine,immunology,and targeted drug delivery
Targimmune therapeutics ag operates in the Pharmaceutical manufacturing industry.
Targimmune therapeutics ag's revenue is 11m - 100m
Targimmune therapeutics ag has 11 - 50 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.